Besufetamig
Product Specifications
CAS Number
3037124-22-1
Target
Integrin, PD-1/PD-L1
Related Pathways
Apoptosis, Cytoskeletal Signaling, Cell Cycle/Checkpoint, Immunology/Inflammation
Bioactivity
Besufetamig is a bispecific antibody targeting programmed cell death protein 1 (PD-1) and the CD3ε chain. It modulates immune cell activity, exerting both immunosuppressive and antitumor effects. Besufetamig holds promise for cancer research.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K1775808 1.0 µg DNA
RABGAP1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)
Sign In for Pricing
View Details NBP2-73253AF594 0.1 mL
Mouse Monoclonal Patched 1/PTCH Antibody (OTI5C7) [Alexa Fluor 594]
Sign In for Pricing
View Details GTR15145105 1 Vial
Lentiviral human EXTL1 shRNA (UAS) - Lentiviral human EXTL1 shRNA (UAS, RFP) plasmid
Sign In for Pricing
View Details 038940-ML405 100 µL
NFKBIA, phosphorylated (Ser32) (NFKBIA, IKBA, MAD3, NFKBI, NF-kappa-B inhibitor alpha, I-kappa-B-alpha, Major histocompatibility complex enhancer-binding protein MAD3) (MaxLight 405) discontinued
Sign In for Pricing
View Details 
IHUFGFR4ARCFCLY50UG 1 Each
Human FGFR4 Active Recombinant Protein C-Fc Tag Lyophilized
Sign In for Pricing
View Details